Realtek stock rises in Taipei as earnings week looms; what traders watch next

Taipei, Jan 26, 2026, 10:02 GMT+8 — Regular session

Shares of Realtek Semiconductor Corp (2379.TW) climbed 1.4% to T$514 in early Taipei trading Monday, beating the broader market’s pace. The stock fluctuated between T$501 and T$515, after closing at T$507 on Friday. Its 52-week range stands at T$432.50 to T$593.00. For the quarter ending Sept. 30, Realtek reported revenue of T$29.49 billion and net profit of T$3.43 billion, both down year-on-year, according to Google Finance. (Google)

The benchmark TAIEX index climbed 0.6% to 32,148.97, following a Friday close of 31,961.51, as Taiwan’s tech-driven market maintained momentum. Monday’s trading has seen it fluctuate between 31,989.86 and 32,184.38. (Google)

Outside Taipei, traders dialed back risk ahead of Wednesday’s U.S. Federal Reserve decision and the potential naming of the next Fed chair, Reuters reported. Marc Chandler, chief market strategist at Bannockburn Capital Markets, noted, “The dollar has been fragile anyway.” (Reuters)

Realtek’s Q4 2025 earnings are projected for release on Jan. 28, according to MarketScreener’s corporate calendar. (MarketScreener)

Attention now turns to Realtek’s take on demand for networking and audio chips—key parts in PCs, routers, and consumer gadgets. Investors want insights on customer inventories and pricing as chipmakers navigate patchy consumer demand.

Realtek may not be the top player in Taiwan’s chip sector, but investors keep an eye on it for clues about basic connectivity demand. Its stock’s broad 52-week range highlights just how fast sentiment shifts when consumer tech takes a hit.

The setup works both ways: a cautious outlook or a fresh dip in profits might wipe out Monday’s gains. Taiwan’s export-driven stocks have also felt the squeeze during recent bouts of risk-off moves tied to global rates and currency swings.

Jan. 28 is the next key date, with Realtek set to release its quarterly results and provide guidance. Traders will also keep a close eye on Wednesday’s Fed statement for any changes that might impact tech stocks worldwide.

Khadija Saeed Latest posts

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

View all

EZZ Life Science Shares Jump 33% Amid Mixed Earnings Outlook
January 25, 2026, 9:19 PM EST. EZZ Life Science Holdings Limited (ASX:EZZ) saw its shares surge 33% in the past month but remains 19% lower over the year. The company's price-to-earnings (P/E) ratio stands at a modest 12.9x, well below the Australian average of 22x, suggesting potential undervaluation or lingering doubts about future earnings. Despite a 9.8% earnings drop last year, EZZ delivered a 363% EPS growth over three years, hinting at strong medium-term performance. The market expects around 23% growth next year, but some investors seem cautious, pushing the share price down. The stock's rebound reflects a risk-versus-reward scenario, with investors weighing steady gains against uncertainties about sustained profitability and market performance.